The Valley Desk

NCT00203021 · Interventional trial

Glatiramer Acetate (Copaxone®) Study to Follow Participants From the First Original Study for Safety and Effectiveness

Overall registry status Completed

Phase 4

Conditions Relapsing-Remitting Multiple Sclerosis

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov